explore -WSS

explore

author：fashion 2025-08-11 11:42:51 - browse：313

Seng Cheng has been working in gene therapy for nearly as long as gene therapy has been a field. As a young scientist in the early 1990s, he was part of one of three teams racing to develop a gene therapy for cystic fibrosis, a high-profile effort that resulted in national headlines, prestigious publications, and zero patients cured.

So he’s seen the field’s highs and lows. Lately, there have been a lot of both, including at Pfizer, the company Cheng called home until this summer. The pharma brought three potentially powerful gene therapies for muscular dystrophy and hemophilia into late-stage trials but, in January, chose to abandon a large portfolio of early stage candidates that relied on the same technology: adeno-associated viruses, or AAVs, a group of small bugs that scientists spent two decades taming into a gene shipping system.

The move seemed emblematic. Across the industry, AAV companies have been struggling, either shelving programs or stopping work altogether, while investors shuttled money toward new technologies such as CRISPR and its various permutations. Longtime researchers feared promising drugs, particularly for ultra-rare diseases, might get lost in the shuffle.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： HPV cancer vaccine study demonstrates efficacy

WSS

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Will General Catalyst be the first of many hospital takeovers?

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

focus

explore

knowledge

Hepatitis C has a cure — but many Americans still lack access to it

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

Dobbs anniversary: the lost opportunity of abortion as health care

Removing probiotics from the NICU could threaten preemies' health

Tori Bowie and the unacceptable rates of Black maternal death

FDA approves Recor Medical high blood pressure device

Trump demands the U.S. pay no more for drugs than other countries … again

EMA weighs against approval for Mirati's lung cancer drug

Malaria cases in Florida and Texas: Here’s what you need to know

Excited delirium, Elijah McClain, and emergency physicians

Wikipedia

EMA weighs against approval for Mirati's lung cancer drug

FDA approves Recor Medical high blood pressure device

Biden White House, tech companies launch new safeguards around emerging AI technology

MoonLake credibility takes another hit with mid

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

knowledge

focus

knowledge

hotspot